DACERZ Trademark

Trademark Overview

On Tuesday, September 3, 2019, a trademark application was filed for DACERZ with the United States Patent and Trademark Office. The USPTO has given the DACERZ trademark a serial number of 88602278. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 18, 2023. This trademark is owned by Pfizer Inc.. The DACERZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
dacerz

General Information

Serial Number88602278
Word MarkDACERZ
Filing DateTuesday, September 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, September 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU EXTENSION 5 GRANTED
Wednesday, January 4, 2023SOU EXTENSION 5 FILED
Thursday, January 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 4, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 21, 2022SOU EXTENSION 4 GRANTED
Thursday, July 21, 2022SOU EXTENSION 4 FILED
Thursday, July 21, 2022SOU TEAS EXTENSION RECEIVED
Thursday, January 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 11, 2022SOU EXTENSION 3 GRANTED
Tuesday, January 11, 2022SOU EXTENSION 3 FILED
Tuesday, January 11, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 14, 2021SOU EXTENSION 2 GRANTED
Wednesday, July 14, 2021SOU EXTENSION 2 FILED
Wednesday, July 14, 2021SOU TEAS EXTENSION RECEIVED
Friday, January 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 27, 2021SOU EXTENSION 1 GRANTED
Wednesday, January 27, 2021SOU EXTENSION 1 FILED
Wednesday, January 27, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 18, 2020ASSIGNED TO LIE
Tuesday, May 12, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 30, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 30, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2019NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2019NON-FINAL ACTION WRITTEN
Thursday, November 14, 2019ASSIGNED TO EXAMINER
Friday, September 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 6, 2019NEW APPLICATION ENTERED

Related Keywords

dacerz preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological